Interestingly, we did not observe a similar protective effect of MBL deficiency in patients receiving i.v. thrombolysis, which in theory should more closely mimic experimental I/R injury than conservative treatment. The gene discussed is MBL2; the disease is hyperinsulinemic hypoglycemia, familial, 4.